QA: AKORN INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2017_AKORN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000003116')"}

Graph

Absolute values for 0000003116, AKORN INC

  xvar xval
0 AssetsCurrent 685,811,000
1 IntangibleAssetsNetIncludingGoodwill 1,043,147,000
2 PropertyPlantAndEquipmentNet 238,404,000
3 remainder_Assets 6,358,000
4 LiabilitiesCurrent 175,555,000
5 LiabilitiesNoncurrent 978,981,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 442,572,000
8 SellingGeneralAndAdministrativeExpense 197,501,000
9 ResearchAndDevelopmentExpense 42,603,000
10 remainder_Expenses 204,444,000
11 remainder_Revenues 1,116,843,000
12 remainder_NetIncome -45,480,000
13 remainder_ComprehensiveNetIncome -4,825,000
  yvar yval
0 Assets 1,973,720,000
1 Liabilities 1,154,536,000
2 Expenses 887,120,000
3 Revenues 1,116,843,000
4 StockholdersEquity 819,184,000
5 NetIncome 184,243,000
6 ComprehensiveNetIncome 181,830,500
7 BaseVar 2,591,262,000
8 EconomicCapitalRatio 1.02

Edgar->Model Mapping

Feature Distribution